Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 12, 2012, Pages 1100-1112

  Dowjat, Karol ^a   Adayev, Tatyana ^a   Kaczmarski, Wojciech ^a   Wegiel, Jerzy ^a   Hwang, Yu Wen ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Actin cytoskeleton; Brain; Coimmunoprecipitation; Down syndrome; DYRK1A kinase; Lymphocytes

Indexed keywords

PROLINE; PROTEIN SERINE THREONINE KINASE;

ACTIN FILAMENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOSKELETON; DOWN SYNDROME; DYRK1A GENE; FEMALE; GENE; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; INFANT; INTELLECTUAL IMPAIRMENT; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADULT; AGE FACTORS; AGED; ANIMALS; BRAIN; CELL LINE, TRANSFORMED; CHILD, PRESCHOOL; CYTOSKELETON; DOWN SYNDROME; FEMALE; GENE DOSAGE; HUMANS; IMMUNOPRECIPITATION; INFANT; INFANT, NEWBORN; LYMPHOCYTES; MALE; MICE; MIDDLE AGED; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; TRANSFECTION;

EID: 84870835308     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31827733c8     Document Type: Article

References (48)

1. Tejedor F, Zhu XR, Kaltenbach E, et al. Minibrain: A new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 1995;14:287-301
2. Himpel S, Tegge W, Frank R, et al. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem 2000;275: 2431-38
3. Guimerá J, Casas C, Pucharcòs C, et al. A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 1996;5:1305-10
4. Rahmani Z, Blouin J-L, Creau-Goldberg N, et al. Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome. Proc Natl Acad Sci USA 1989;86:5958-62
5. Belichenko NP, Belichenko PV, Kleschevnikov AM, et al. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 2009;29:5938-48
6. Dowjat WK, Adayev T, Kuchna I, et al. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett 2007;413:77-81
7. Hämmerle B, Carnicero A, Elizalde C, et al. Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation. Eur J Neurosci 2003;17:2277-86
8. Hammerle B, Elizalde C, Tejedor FJ. The spatiotemporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development. Eur J Neurosci 2008;27:1061-74
9. Branchi I, Bichler Z, Minghetti L, et al. Transgenic mouse in vivo library of human Down syndrome critical region 1: Association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. J Neuropathol Exp Neurol 2004;63: 429-40
10. Fotaki V, Dierssen M, Alcantara S, et al. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 2002;22:6636-47
11. Marti E, Altafaj X, Dierssen M, et al. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res 2003;964:250-63
12. Ferrer I, Barrachina M, Puig B, et al. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol Dis 2005;20:392-400
13. Dierssen M, Ramakers GJ. Dendritic pathology in mental retardation: From molecular genetics to neurobiology. Genes Brain Behav 2006; 5(Suppl 2):48-60
14. Ahn KJ, Jeong HK, Choi HS, et al. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol Dis 2006;22:463-72
15. Altafaj X, Dierssen M, Baamonde C, et al. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum Mol Genet 2001;10:1915-23
16. Dierssen M, Benavides-Piccione R, Martinez-Cue C, et al. Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: Effects of environmental enrichment. Cereb Cortex 2003;13:758-64
17. Smith DJ, Stevens ME, Sudanagunta SP, et al. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet 1997;16:28-36
18. van Bon BW, Hoischen A, Hehir-Kwa J, et al. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin Genet 2011;79:296-99
19. Moller RS, Kubart S, Hoeltzenbein M, et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am J Hum Genet 2008;82:1165-70
20. Chettouh Z, Croquette MF, Delobel B, et al. Molecular mapping of 21 features associated with partial monosomy 21: Involvement of the APP-SOD1 region. Am J Hum Genet 1995;57:62-71
21. Matsumoto N, Ohashi H, Tsukahara M, et al. Possible narrowed assignment of the loci of monosomy 21Yassociated microcephaly and intrauterine growth retardation to a 1.2-Mb segment at 21q22.2. Am J Hum Genet 1997;60:997-99
22. Fujita H, Torii C, Kosaki R, et al. Microdeletion of the Down syndrome critical region at 21q22. Am J Med Genet A 2010;152A:950-53
23. Oegema R, de Klein A, Verkerk AJ, et al. Distinctive phenotypic abnormalities associated with submicroscopic 21q22 deletion including DYRK1A. Mol Syndromol 2010;1:113-20
24. Benavides-Piccione R, Dierssen M, Ballesteros-Yanez I, et al. Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/-mouse. Neurobiol Dis 2005;20:115-22
25. Park J, Yang EJ, Yoon JH, et al. Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome. Mol Cell Neurosci 2007;36:270-79
26. Yang EJ, Ahn YS, Chung KC. Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells. J Biol Chem 2001;276:39812-24
27. Martinez de Lagran M, Benavides-Piccione R, Ballesteros-Yanez I, et al. Dyrk1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons. Cereb Cortex 2012 [Epub ahead of print] doi:1093/cercor/bhr362
28. Park J, Song WJ, Chung KC. Function and regulation of Dyrk1A: Towards understanding Down syndrome. Cell Mol Life Sci 2009;66: 3235-40
29. Aranda S, Laguna A, de la Luna S. DYRK family of protein kinases: Evolutionary relationships, biochemical properties, and functional roles. FASEB J 2011;25:449-62
30. Becker W, Weber Y, Wetzel K, et al. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 1998;273: 25893-902
31. Murakami N, Bolton D, Hwang YW. Dyrk1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles. Biochemistry 2009;48:9297-305
32. Kida E, Walus M, Jarzabek K, et al. Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals. Neuroscience 2011;195: 112-27
33. Wegiel J, Kuchna I, Nowicki K, et al. Cell typeY and brain structureY specific patterns of distribution of minibrain kinase in human brain. Brain Res 2004;1010:69-80
34. Guimerá J, Casas C, Estivill X, et al. Human minibrain homologue (MNBH/DYRK1): Characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 1999; 57:407-18
35. Adayev T, Chen-Hwang MC, Murakami N, et al. Kinetic property of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways. Biochemistry 2006;45:12011-19
36. Nadel L. Down's syndrome: A genetic disorder in biobehavioral perspective. Genes Brain Behav 2003;2:156-66
37. Becker L, Mito T, Takashima S, et al. Growth and development of the brain in Down syndrome. Prog Clin Biol Res 1991;373:133-52
38. Schmidt-Sidor B, Wisniewski KE, Shepard TH, et al. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 1990;9:181-90
39. Weitzdoerfer R, Dierssen M, Fountoulakis M, et al. Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure. J Neural Transm Suppl 2001;61:59-70
40. Vuksic M, Petanjek Z, Rasin MR, et al. Perinatal growth of prefrontal layer III pyramids in Down syndrome. Pediatr Neurol 2002;27:36-38
41. Gockler N, Jofre G, Papadopoulos C, et al. Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J 2009;276:6324-37
42. Lepagnol-Bestel AM, Zvara A, Maussion G, et al. DYRK1A interacts with the REST/NRSF-SWI/SNF chromatin remodelling complex to deregulate gene clusters involved in the neuronal phenotypic traits of Down syndrome. Hum Mol Genet 2009;18:1405-14
43. Liu T, Sims D, Baum B. Parallel RNAi screens across different cell lines identify generic and cell typeYspecific regulators of actin organization and cell morphology. Genome Biol 2009;10:R26
44. Guedj F, Sebrie C, Rivals I, et al. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS One 2009;4: e4606.
45. Winder SJ, Ayscough KR. Actin-binding proteins. J Cell Sci 2005;118:651-54
46. Park J, Sung JY, Song WJ, et al. Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP. J Cell Sci 2012;125:67-80
47. Csermely P, Schnaider T, Soti C, et al. The 90-kDa molecular chaperone family: Structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 1998;79:129-68
48. Dowjat K. DYRK1A kinase and neuronal cytoskeleton: A new look at pathogenesis of Alzheimer's disease dementia from the perspective of Down syndrome. In: Jelinek G, Dvorak G, eds. Handbook of Down Syndrome Research. New York, NY: Nova Science Publishers, Inc., 2009:690-96